During the past decade, Lourdes Cardiology Services conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lourdes Cardiology Services" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Lourdes Cardiology Services" in a lesser frequency.

Most popular intervention types in "Lourdes Cardiology Services" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lourdes Cardiology Services" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lourdes Cardiology Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Lourdes Cardiology Services, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lourdes Cardiology Services, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".